

share
Zanolimumab CAS NO 652153-01-0
Unit Price:
CAS No.:652153-01-0
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Zanolimumab is a fully human monoclonal antibody designed for targeted therapeutic intervention. This high-purity biological agent is critical for research and development in advanced immunology and oncology. It is primarily utilized by pharmaceutical developers, biotechnology research institutions, and clinical laboratories focused on innovative treatment modalities.
Application
- Biopharmaceutical R&D: Serves as a key reference standard and active ingredient in the development of novel immunotherapies.
- Mechanism of Action Studies: Used in preclinical and clinical research to investigate specific immunological pathways and cellular responses.
- Process Development & Scale-up: Employed in the optimization of upstream and downstream manufacturing processes for monoclonal antibody production.
- Analytical Method Development: Acts as a critical material for validating bioanalytical assays, including potency, purity, and stability testing.
- Cell-Based Assays: Utilized in functional in vitro assays to evaluate efficacy and specificity against target antigens.
Basic Information
| Product Name | Zanolimumab |
| CAS No. | 652153-01-0 |
| Molecular Formula | Contact for details |
| Molecular Weight | Approx. 145-150 kDa |
| Synonyms | HuMax-CD4; Anti-CD4 Monoclonal Antibody; Fully Human Anti-CD4 IgG1κ; Monoclonal Antibody CD4; Therapeutic Anti-CD4 Antibody; CD4 Inhibitor; TNX-355 (related investigational name); Anti-CD4 |
| EINECS | Contact for details |
Quality Control
Our Zanolimumab is manufactured under strict quality systems. Each batch is subjected to a comprehensive battery of analytical tests to ensure identity, purity, potency, and safety, aligning with ICH Q6B guidelines for biotechnological products. Certificates of Analysis (COA) documenting full specifications and test results are available upon request.
Storage
Preserve in a tightly closed container, protected from light. For long-term stability, store at -20°C or below. Avoid repeated freeze-thaw cycles. Refer to the specific Certificate of Analysis for detailed storage and handling instructions.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white lyophilized powder or clear to slightly opalescent solution |
| Identification (HPLC/MS) | Conforms to reference standard |
| Purity (SEC-HPLC) | ≥ 95.0% Monomer |
| Assay (UV/Functional) | 90.0% - 110.0% of label claim |
| Endotoxin | < 1.0 EU/mg |
| Host Cell Protein | < 100 ppm |
| Sterility (where applicable) | Sterile |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Pembrolizumab CAS NO 1374853-91-4


Tuvirumab CAS NO 138660-97-6


Biciromab CAS NO 138783-13-8


Muromonab-Cd3 CAS NO 140608-64-6


Anti-Stromelysin-2 CAS NO 140610-48-6


Gendevit CAS NO 141910-80-7


Edrecolomab CAS NO 156586-89-9


Felvizumab CAS NO 167747-20-8


Faralimomab CAS NO 167816-91-3


Rovelizumab [Usan:Inn] CAS NO 197099-66-4


Teprotumumab CAS NO 1036734-93-6


Monalizumab CAS NO 1228763-95-8


Anifrolumab CAS NO 1326232-46-5


Anti-Br140-Like Protein Antibody Produced In Rabbit CAS NO 1597439-92-3


Eptinezumab CAS NO 1644539-04-7


Rhumab Cd 168 CAS NO 211323-03-4


Ociperlimab CAS NO 2342597-93-5


Tadocizumab CAS NO 339086-80-5


Galiximab CAS NO 357613-77-5


Tocilizumab CAS NO 375823-41-9
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.





